A detailed history of Park Place Capital Corp transactions in Biogen Inc. stock. As of the latest transaction made, Park Place Capital Corp holds 7 shares of BIIB stock, worth $1,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 7 -0.0%
Holding current value
$1,216
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$212.02 - $267.71 $1,484 - $1,873
7 New
7 $1,000
Q3 2023

Oct 17, 2023

SELL
$253.3 - $285.89 $506 - $571
-2 Reduced 22.22%
7 $1,000
Q2 2023

Aug 04, 2023

SELL
$275.25 - $318.06 $3,303 - $3,816
-12 Reduced 57.14%
9 $2,000
Q1 2023

May 02, 2023

BUY
$256.56 - $292.34 $3,591 - $4,092
14 Added 200.0%
21 $5,000
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $1,767 - $2,147
7 New
7 $2,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.